1. Ajuriaguerra, J. de, Constantinidis, J., Eisenring, J. J., Yanniotis, G., Tissot, R.: Behaviour disorders and l-DOPA therapy in Parkinson's syndrome. In: Parkinson's disease, Vol. 1, J. Siegfried, ed., pp. 201?217. Bern-Stuttgart-Vienna: H. Huber 1972
2. De Alarcon, R., Carney, M. W. P.: Severe depressive mood changes following slow-release intramuscular fluphenazine injection. Brit. Med. J. 1969III, 564?567
3. Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T., Rydin, C., Svensson, R.: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci. 9, 513?523 (1970)
4. Blomberg, L.-H., Eriksson, G.: Imipramin (Tofranil) vid behandling av parkinsonism. Svenska LÄk.-Tidn. 58, 2500?2503 (1961)
5. Carlsson, A., Corrodi, H., Fuxe, K., Hökfelt, T.: Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,?-dimethyl-meta-tyramine. Europ. J. Pharmol. 5, 367?373 (1969)